Role, race, and place: Prostate cancer disparities in Patients' and Partners' health outcomes and psychosocial factors.
area deprivation index (ADI)
health disparities
prostate cancer
psychosocial factors
quality of life
stress coping
symptom
Journal
Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
revised:
18
12
2022
received:
05
07
2022
accepted:
13
01
2023
medline:
10
5
2023
pubmed:
8
2
2023
entrez:
7
2
2023
Statut:
ppublish
Résumé
This study aimed to examine the effects of participant role (patient vs. partner), race (white vs. non-white), and place (less vs. more neighborhood deprivation) on health outcomes (quality of life [QOL] and symptoms) and stress-coping-related psychosocial factors (appraisals of illness and coping resources). This descriptive study included 273 patients and their partners (dyads) who transitioned from PCa treatment to self-management. We used established, psychometrically sound measures to assess health outcomes and psychosocial factors and conducted multilevel modeling analyses. Compared to partners, patients reported worse physical QOL; less frequent anxiety; less pain and fatigue; less bothersome hormonal problems; more bothersome urinary and sexual problems; greater self-efficacy; and more instrumental support. Compared to their white counterparts, non-white dyads reported better overall, emotional, and functional QOL; less depression; more positive appraisals, and greater self-efficacy. Compared to dyads in low ADI neighborhoods, dyads in high ADI (more deprived) neighborhoods reported worse social QOL; more bothersome urinary, sexual, and hormonal symptoms; and less interpersonal support. White patients reported the highest emotional support among all groups, while white partners reported the lowest emotional support. Our findings underscore the need to consider social determinants of health at multiple levels when investigating PCa disparities. Considering neighborhood-level socioeconomic factors, in addition to race and role, improves our understanding of the PCa disparities in QOL, symptoms, and psychosocial factors among patients and partners. Targeted multilevel supportive care interventions should tailor to the needs of racially diverse PCa patients and partners residing in deprived neighborhoods are needed.
Identifiants
pubmed: 36748581
doi: 10.1002/cam4.5646
pmc: PMC10166971
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
9857-9867Informations de copyright
© 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Références
Nat Clin Pract Oncol. 2008 Aug;5(8):466-75
pubmed: 18493231
BMC Med Res Methodol. 2009 Jul 14;9:49
pubmed: 19602263
J Urol. 2020 Jan;203(1):108-114
pubmed: 31430233
Qual Life Res. 2011 Apr;20(3):371-81
pubmed: 20927648
Cancer Causes Control. 2012 Jul;23(7):1185-91
pubmed: 22674292
Cancer Nurs. 2013 May-Jun;36(3):E7-E14
pubmed: 22565105
Support Care Cancer. 2012 Jun;20(6):1267-74
pubmed: 21710307
Am J Surg. 2021 Jul;222(1):10-17
pubmed: 33308823
Qual Life Res. 2020 Aug;29(8):2241-2252
pubmed: 32246432
J Clin Oncol. 1993 Mar;11(3):570-9
pubmed: 8445433
BMC Psychiatry. 2020 Apr 6;20(1):154
pubmed: 32252700
Patient Educ Couns. 2015 May;98(5):633-9
pubmed: 25648280
Scand J Urol. 2016;50(1):47-55
pubmed: 26343525
Prostate Int. 2020 Jun;8(2):49-54
pubmed: 32647640
Prev Med Rep. 2017 Aug 09;8:108-111
pubmed: 28966907
Front Neuroendocrinol. 2014 Aug;35(3):320-30
pubmed: 24887405
Front Oncol. 2019 Apr 08;9:238
pubmed: 31024842
Urology. 1997 Dec;50(6):920-8
pubmed: 9426724
Cold Spring Harb Perspect Med. 2018 Sep 4;8(9):
pubmed: 29229666
Cancer Med. 2023 Apr;12(8):9857-9867
pubmed: 36748581
Cancer Epidemiol. 2018 Apr;53:1-11
pubmed: 29328959
Asian Pac J Cancer Prev. 2015;16(3):1259-75
pubmed: 25735366
Eur Urol Oncol. 2022 Feb;5(1):18-29
pubmed: 34446369
Cancer. 2021 Sep 15;127(18):3476-3485
pubmed: 34061986
Int J Cancer. 2018 Jun 15;142(12):2478-2484
pubmed: 29363113
N Engl J Med. 2018 Jun 28;378(26):2456-2458
pubmed: 29949490
Trials. 2022 Jan 4;23(1):12
pubmed: 34983621
Cancer Causes Control. 2009 Oct;20(8):1431-40
pubmed: 19526319
Ann Intern Med. 2014 Dec 2;161(11):765-74
pubmed: 25437404
Eur Urol. 2014 Dec;66(6):1054-64
pubmed: 25242554
Urology. 2000 Dec 20;56(6):899-905
pubmed: 11113727
J Clin Oncol. 2007 Sep 20;25(27):4171-7
pubmed: 17635953
Br J Cancer. 2021 Jan;124(2):315-332
pubmed: 32901135
Int J Epidemiol. 2003 Jun;32(3):357-66
pubmed: 12777420
Cancer Epidemiol Biomarkers Prev. 2020 Jul;29(7):1357-1364
pubmed: 32303533